3 free views remaining today
Mayer-Rokitansky-Kuster-Hauser syndrome type 1
Description
Signs and Symptoms
Common Signs and Symptoms of MRKH Syndrome Type 1
Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome type 1 is a rare congenital disorder that affects the female reproductive system. The primary signs and symptoms of this condition include:
- Primary Amenorrhea: The most common symptom of MRKH syndrome type 1 is the absence of menstrual periods by age 16 [3][9].
- Underdeveloped or Absent Vagina and Uterus: In most cases, the vagina and uterus are either underdeveloped or completely absent [1][2][4][6][7][11].
- Normal Pubic Hair and Breast Development: Girls with MRKH syndrome type 1 typically experience normal pubic hair and breast development during puberty [8].
It's essential to note that these symptoms may not be present in all cases, and some individuals may have additional signs or symptoms. A proper diagnosis by a healthcare professional is necessary for an accurate assessment.
References:
[1] Context result 1 [2] Context result 2 [3] Context result 9 [4] Context result 10 [6] Context result 12 [7] Context result 13 [8] Context result 8 [11] Context result 11
Additional Symptoms
- Primary Amenorrhea
- Underdeveloped or Absent Vagina and Uterus
- Normal Pubic Hair and Breast Development
Diagnostic Tests
Diagnostic Tests for MRKH Syndrome Type 1
Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome type 1 is a rare congenital disorder that affects the female reproductive system. The diagnosis of MRKH syndrome type 1 often occurs in later adolescence, when a young woman hasn't started her period.
Diagnostic Process
The diagnostic process for MRKH syndrome type 1 typically involves a combination of medical history, physical examination, and various tests to confirm the absence or underdevelopment of the uterus and vagina. The following tests are commonly used:
- Pelvic Examination: A healthcare provider will perform a pelvic exam to check for any abnormalities in the reproductive organs.
- Imaging Studies: Imaging studies such as ultrasound, MRI (Magnetic Resonance Imaging), or CT scans may be ordered to confirm the absence or underdevelopment of the uterus and vagina. [3][7]
- Blood Tests: Blood tests may be conducted to check hormone levels and chromosomes. [8]
- Pelvic Ultrasound: A pelvic ultrasound may be performed to visualize the reproductive organs and confirm the diagnosis. [8]
Diagnostic Criteria
The diagnostic criteria for MRKH syndrome type 1 include:
- Absence or underdevelopment of the uterus
- Absence or underdevelopment of the upper two-thirds of the vagina
- Normal ovaries and fallopian tubes
- Normal external genitalia
Specialist Referrals
It is essential to work with an engaged and dedicated primary care provider (PCP) or pediatrician, who can order diagnostic tests, refer you to specialists, and serve as a connecting point for further care. [10]
References:
[3] Govindarajan M, Rajan RS, Kalyanpur A, Ravikumar. Magnetic resonance imaging diagnosis of Mayer-Rokitansky-Küster-Hauser syndrome.
[7] by MJ Govindarajan · 2008 · Cited by 40 — Therefore, we conclude that MRI is the mainstay of imaging evaluation of MRKH syndrome, not only to confirm clinically diagnosed Mullerian anomalies of uterus ...
[8] Learn about diagnosis and specialist referrals for Mayer-Rokitansky-Küster-Hauser syndrome type 1.
[10] Working with an engaged and dedicated PCP or pediatrician is important because they can order diagnostic tests, refer you to specialists, and are often the connecting point for further care.
Treatment
Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome type 1 is a congenital disorder characterized by the underdevelopment or absence of the uterus and upper vagina in females. While there is no cure for MRKH syndrome, various treatment options are available to address its symptoms.
Vaginal Dilators
One of the most commonly used treatments for MRKH syndrome type 1 is vaginal dilators. These are devices that help to gradually stretch and widen the vaginal opening, making it more comfortable and easier to use for sexual activity. Vaginal dilators can be used in conjunction with estrogen therapy to promote vaginal lubrication and elasticity.
Estrogen Therapy
Estrogen therapy is another treatment option for MRKH syndrome type 1. This involves taking estrogen hormones to stimulate the growth of the vaginal lining, making it more comfortable and easier to use for sexual activity. Estrogen therapy can also help to improve vaginal lubrication and reduce symptoms of vaginal dryness.
Surgical Options
In some cases, surgical options may be necessary to create a neovagina or to address other related issues. These procedures are typically performed by a gynecologist or urologist who specializes in the treatment of MRKH syndrome. Surgical options may include:
- Neovaginoplasty: This is a surgical procedure that creates a new vagina using tissue from another part of the body.
- Vaginoplasty: This is a surgical procedure that widens and deepens the vaginal opening.
Other Treatment Options
In addition to vaginal dilators, estrogen therapy, and surgical options, other treatment options may be available for MRKH syndrome type 1. These may include:
- Physical therapy: This can help to improve vaginal elasticity and reduce symptoms of vaginal dryness.
- Counseling: This can provide emotional support and guidance on how to manage the physical and emotional challenges associated with MRKH syndrome.
It's essential to note that each individual with MRKH syndrome type 1 is unique, and the most effective treatment plan will depend on their specific needs and circumstances. A healthcare provider who specializes in the treatment of MRKH syndrome can provide personalized guidance and support.
References:
- [4] by A Pizzo · 2013 · Cited by 132 — Currently, the most widely nonsurgical used techniques include the “Frank's dilators method,” while the surgical ones most commonly used are those developed by ...
- [9] Oct 16, 2020 — VD therapy should be recommended as first-line treatment for the creation of a neovagina in patients with MRKH syndrome, following careful ...
Recommended Medications
- Physical therapy
- Estrogen Therapy
- Vaginal Dilators
- Neovaginoplasty
- Vaginoplasty
💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.
Differential Diagnosis
Differential Diagnosis of MRKH Syndrome Type 1
Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome type 1, also known as isolated utero-vaginal aplasia, is a congenital disorder characterized by the absence or underdevelopment of the uterus and upper part of the vagina in females with normal secondary sex characteristics and a normal female karyotype (46,XX). To determine if someone has MRKH syndrome type 1, it's essential to rule out other conditions that may present similar symptoms. Here are some key points to consider:
- Androgen Insensitivity Syndrome (AIS): AIS is a genetic condition where an individual is genetically male (XY) but resistant to androgens, leading to the development of female secondary sex characteristics. However, unlike MRKH syndrome type 1, individuals with AIS have normal internal reproductive organs, including a uterus and ovaries [11].
- Congenital Absence of Vagina: This condition refers to the complete or partial absence of the vagina at birth. While it may present similar symptoms to MRKH syndrome type 1, it is typically associated with other congenital anomalies and often requires surgical intervention for vaginal creation.
- Uterine Agenesis: This rare condition involves the complete or partial absence of the uterus, which can be isolated or part of a larger syndrome. However, unlike MRKH syndrome type 1, uterine agenesis is not typically associated with upper vagina
Additional Information
- oboInOwl#hasOBONamespace
- disease_ontology
- oboInOwl#id
- DOID:0112178
- core#notation
- DOID:0112178
- oboInOwl#hasDbXref
- ORDO:247775
- IAO_0000115
- A Mayer-Rokitansky-Kuster-Hauser syndrome characterized by isolated utero-vaginal atresia in patients with an otherwise normal 46 XX karyotype.
- oboInOwl#hasExactSynonym
- Rokitansky sequence
- rdf-schema#label
- Mayer-Rokitansky-Kuster-Hauser syndrome type 1
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/doid#DO_rare_slim
- rdf-schema#subClassOf
- http://purl.obolibrary.org/obo/DOID_0112177
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_symptom_6688
- owl#annotatedSource
- t388755
Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.
It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.